Table 2.
Comparison of histopathological parameters for gastric cancer patients with and with no autoimmune gastritis (AIG).
| Parameter | AIG | No AIG | p-value | OR (95% CI) |
|---|---|---|---|---|
| N a | 26 | 52 | ||
| Atrophy of corpus grade 1–3 (%) | 26 (100) | 15 (27) | 0.000 | 16.7 (6.6–42.7) |
| No atrophy (%) | 0 (0) | 38 (73) | – | – |
| Grade 1 (%) | 0 (0) | 8 (15) | – | – |
| Grade 2 (%) | 7 (27) | 5 (10) | – | – |
| Grade 3 (%) | 19 (73) | 1 (2) | 0.000 | 138.4 (15.6–1201.0) |
| Atrophy of antrum grade 1–3 (%) | 9 (34) | 23 (44) | 0.416 | 1.5 (0.6–4.0) |
| No atrophy (%) | 17 (66) | 29 (56) | – | – |
| Grade 1 (%) | 7 (27) | 13 (25) | – | – |
| Grade 2 (%) | 2 (7) | 6 (11) | – | – |
| Grade 3 (%) | 0 (0) | 4 (8) | – | – |
| IM of corpus grade 1–3 (%) | 18 (69) | 4 (8) | 0.000 | 27.0 (7.2–100.8) |
| No IM (%) | 8 (31) | 48 (92) | – | – |
| Grade 1 (%) | 4 (15) | 2 (4) | – | – |
| Grade 2 (%) | 7 (27) | 1 (2) | – | – |
| Grade 3 (%) | 7 (27) | 1 (2) | 0.0006 | 18.8 (2.2–163.0) |
| IM of antrum grade 1–3 (%) | 12 (46) | 13 (25) | 0.059 | 2.6 (0.9–6.9) |
| No IM (%) | 14 (54) | 39 (75) | – | – |
| Grade 1 (%) | 6 (24) | 4 (8) | – | – |
| Grade 2 (%) | 5 (19) | 9 (17) | – | – |
| Grade 3 (%) | 1 (3) | 0 (0) | – | – |
a
26/28 (93%) with appropriate scoring according to the Sydney classification.
CI: confidence interval; OR: odds ratio; IM: intestinal metaplasia.
p-values ≤ 0.05 (bold) are statistically significant (X2 test).